Literature DB >> 21296855

Global cancer statistics.

Ahmedin Jemal1, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman.   

Abstract

The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.

Entities:  

Mesh:

Year:  2011        PMID: 21296855     DOI: 10.3322/caac.20107

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  2000 in total

1.  Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Authors:  Kristina G Flores; Christine A Stidley; Amanda J Mackey; Maria A Picchi; Sally P Stabler; Jill M Siegfried; Tim Byers; Marianne Berwick; Steven A Belinsky; Shuguang Leng
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

2.  Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.

Authors:  Wei-Bin Zheng; Yang-Jia Li; Yang Wang; Jie Yang; Can-Can Zheng; Xiao-Hui Huang; Bin Li; Qing-Yu He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

3.  Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

Authors:  Dengke Yang; Guang Du; An Xu; Xuetao Xi; Dong Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  Characterization of adenoviral transduction profile in prostate cancer cells and normal prostate tissue.

Authors:  Jianzhong Ai; Phillip W L Tai; Yi Lu; Jia Li; Hong Ma; Qin Su; Qiang Wei; Hong Li; Guangping Gao
Journal:  Prostate       Date:  2017-07-20       Impact factor: 4.104

Review 5.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

6.  Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis.

Authors:  Jhe-Cyuan Guo; Chin-Chen Chang; Chung-Yi Yang; Bin-Chi Liao; Jau-Yu Liau; Chin-Hao Chang; Kun-Huei Yeh
Journal:  Med Oncol       Date:  2017-07-19       Impact factor: 3.064

7.  Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device.

Authors:  Bee Luan Khoo; Gianluca Grenci; Ying Bena Lim; Soo Chin Lee; Jongyoon Han; Chwee Teck Lim
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

8.  The Importance of Safety-Net Hospitals in Emergency General Surgery.

Authors:  Vikrom K Dhar; Young Kim; Koffi Wima; Richard S Hoehn; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

9.  Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma.

Authors:  Sukjin Koh; Erik J Maki; Kenneth J Kolbeck; Khashayar Farsad
Journal:  Radiol Case Rep       Date:  2018-04-05

10.  Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Authors:  Erika B Dugo; Clement G Yedjou; Jacqueline J Stevens; Paul B Tchounwou
Journal:  Ann Clin Pathol       Date:  2017-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.